Early Termination of Clinical Trials [předčasné ukončení klinických zkoušek]

topical
16
Terms

klinické zkoušky - předčasné ukončení

Persistent link   https://www.medvik.cz/link/D057239
Definition

Earlier than planned termination of clinical trials.

DUI
D057239 MeSH Browser
CUI
M0535191
Previous indexing
Research Design (1994-2009)
History note
2010
Public note
2010

Allowable subheadings

AE
adverse effects
EC
economics
ES
ethics
HI
history
LJ
legislation & jurisprudence
MT
methods
MO
mortality 2
NU
nursing
PX
psychology
ST
standards
SN
statistics & numerical data
TD
trends
VE
veterinary

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E01 Diagnosis 1 790
E01.789 Prognosis 9 661
E01.789.800 Treatment Outcome 21 703
E01.789.800.190 Disease-Free Survival 1 445
E01.789.800.238 Early Termination of Clinical Trials 16
E01.789.800.262 Pathologic Complete Response 7
E01.789.800.285 Progression-Free Survival 495
E01.789.800.379 Response Evaluation Criteria in Solid Tumors 42
E01.789.800.570 Sustained Virologic Response 19
E01.789.800.665 Therapeutic Index 6
E01.789.800.713 Treatment Expectations
E01.789.800.760 Treatment Failure 673
E05 Investigative Techniques 209
E05.581 Methods 2 004
E05.581.500 Research Design 1 376
E05.581.500.149 Control Groups 26
E05.581.500.300 Double-Blind Method 1 476
E05.581.500.400 Early Termination of Clinical Trials 16
E05.581.500.501 Meta-Analysis as Topic 1 790
E05.581.500.577 Meta-Research
E05.581.500.653 Patient Selection 1 135
E05.581.500.805 Random Allocation 215
E05.581.500.902 Sample Size 43

N Health Care
N04 Health Services Administration 1 738
N04.761 Quality of Health Care 2 492
N04.761.559 Outcome and Process Assessment, Health Care 1 870
N04.761.559.590 Outcome Assessment, Health Care 584
N04.761.559.590.800 Treatment Outcome 21 703
N04.761.559.590.800.190 Disease-Free Survival 1 445
N04.761.559.590.800.379 Early Termination of Clinical Trials 16
N04.761.559.590.800.427 Pathologic Complete Response 7
N04.761.559.590.800.474 Progression-Free Survival 495
N04.761.559.590.800.569 Response Evaluation Criteria in Solid Tumors 42
N04.761.559.590.800.665 Sustained Virologic Response 19
N04.761.559.590.800.713 Therapeutic Index 6
N04.761.559.590.800.737 Treatment Expectations
N04.761.559.590.800.760 Treatment Failure 673
N05 Health Care Quality, Access, and Evaluation 685
N05.715 Quality of Health Care 2 492
N05.715.360 Health Care Evaluation Mechanisms 200
N05.715.360.575 Outcome and Process Assessment, Health Care 1 870
N05.715.360.575.575 Outcome Assessment, Health Care 584
N05.715.360.575.575.800 Treatment Outcome 21 703
N05.715.360.575.575.800.190 Disease-Free Survival 1 445
N05.715.360.575.575.800.379 Early Termination of Clinical Trials 16
N05.715.360.575.575.800.427 Pathologic Complete Response 7
N05.715.360.575.575.800.474 Progression-Free Survival 495
N05.715.360.575.575.800.569 Response Evaluation Criteria in Solid Tumors 42
N05.715.360.575.575.800.665 Sustained Virologic Response 19
N05.715.360.575.575.800.713 Therapeutic Index 6
N05.715.360.575.575.800.737 Treatment Effect Heterogeneity
N05.715.360.575.575.800.749 Treatment Expectations
N05.715.360.575.575.800.760 Treatment Failure 673

Add